Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

20.40
Delayed Data
As of Jul 30
 -0.05 / -0.24%
Today’s Change
7.31
Today|||52-Week Range
21.50
+145.78%
Year-to-Date

Today’s Trading

Previous close20.45
Today’s open20.31
Day’s range19.60 - 20.75
Volume690,110
Average volume (3 months)1,146,644
Market cap$976.8M
Dividend yield--
Data as of 3:59pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-51.56%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio28.9
Price/Sales3.44
Price/Book12.32

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...-0.49-2.29%
ZFGNZafgen Inc-0.17-0.47%
ACHNAchillion Pharmaceut...-0.02-0.24%
ARNAArena Pharmaceutical...-0.12-2.93%
Data as of 4:14pm ET, 07/30/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts